HALO logo
halo search icon
Novavax, Inc.

US$8.98

Price Change Indicator
-0.29 (-3.128%)
Novavax, Inc.
NVAX · NAS

Novavax, Inc.

Start Trading NVAX for Free

US$8.98

Price Arrow-0.29 (-3.128%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Balance SheetHALO Capital EfficiencyHammer BearishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Novavax, Inc. Overview

NVAX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About NVAX

icon
icon

Telephone

1.240.268.2000

icon

Address

21 Firstfield Road, Gaithersburg, MD 20878

Description

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

NVAX Price Chart

Key Stats

Market Cap

US$1.52B

PE

2.60

EV/EBITDA

1.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 6.13 - 11.97

Trade Value (12mth)

US$10,474,781.00

1 week

2.32%

1 month

9.7%

YTD

30.01%

1 year

27.16%

All time high

331.68

Key Fundamentals

EPS 3 yr Growth

-132.30%

EBITDA Margin

52.60%

Operating Cashflow

-$245m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

26.20

Quick Ratio

2.10

Other Data

Shares Outstanding (Fully Diluted)

163m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

NVAX Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
27 February 26
27 February 26

NVAX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-5.41-1.232.72locklocklock
EPS (Fully Diluted)
 $locklocklocklock-5.41-1.232.54locklocklock
Growth
 %locklocklocklock35.777.2320.6locklocklock
PE
 XlocklocklocklockN/AN/A2.6locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A1.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Novavax, Inc. (NVAX:NAS)?
Halo FAQ
The current share price of Novavax, Inc. (NVAX:NAS) is USD$8.98.
What is the 52-week high share price for Novavax, Inc. (NVAX:NAS)?
Halo FAQ
The 52-week high share price for Novavax, Inc. (NVAX:NAS) is USD$11.97.
What is the 52-week low share price for Novavax, Inc. (NVAX:NAS)?
Halo FAQ
The 52-week low share price for Novavax, Inc. (NVAX:NAS) is USD$6.13.
What is the dividend yield for Novavax, Inc. (NVAX:NAS)?
Halo FAQ
Novavax, Inc. (NVAX:NAS) does not pay a dividend.
What was Novavax, Inc. (NVAX:NAS) last dividend payment?
Halo FAQ
Novavax, Inc. (NVAX:NAS) does not pay a dividend.
What is the franking level for Novavax, Inc. (NVAX:NAS)?
Halo FAQ
Novavax, Inc. (NVAX:NAS) has a franking level of 0.00%.
In which sector is Novavax, Inc. (NVAX:NAS) classified?
Halo FAQ
Novavax, Inc. (NVAX:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Novavax, Inc. (NVAX:NAS)?
Halo FAQ
The current P/E ratio for Novavax, Inc. (NVAX:NAS) is 2.60.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial